41
Participants
Start Date
April 19, 2022
Primary Completion Date
July 11, 2022
Study Completion Date
October 1, 2022
Inmunoferon
The dosage regimen is two capsules (with the active ingredients) per day in a single dose.The study lasted 8 weeks, with 2 interventional visits at baseline and at 8 weeks. Blood samples are collected twice: once on day 0 of the study and again at the final visit.
Placebo
The dosage regimen is two capsules (with inert ingredients) per day in a single dose.The study lasted 8 weeks, with 2 interventional visits at baseline and at 8 weeks. Blood samples are collected twice: once on day 0 of the study and again at the final visit.
Facultad de Biología Universidad Complutense de Madrid, Madrid
Industrial Farmacéutica Cantabria, S.A.
INDUSTRY